Despite earlier concerns about CBD's genotoxicity, this study found that CBD did not cause DNA double-strand breaks in human liver-derived HepG2 cells at concentrations up to 50 μM, challenging previous findings and supporting CBD's safety profile.
Toxicologists, regulators assessing CBD safety, healthcare providers counseling patients on CBD, and CBD consumers.
What the researchers found
CBD (5–50 μM, 3–72h incubation) did not induce DNA double-strand breaks in HepG2 cells. The study also investigated CB1/CB2 receptor expression balance in HepG2 cells, providing context for understanding CBD's interactions with liver cells. Results counter previous reports of CBD-induced genotoxicity in liver cell lines.
Why it matters
Previous studies raised concerns that CBD might damage DNA in liver cells at low concentrations, potentially limiting its therapeutic applications. This study provides reassuring evidence that CBD does not cause the most dangerous form of DNA damage (double-strand breaks) in a relevant liver cell model.
The numbers in context
CBD concentrations: 5–50 μM. Incubation: 3–72 hours. Cell line: HepG2 (human liver-derived). No DNA double-strand breaks detected at any concentration or time point.
How the study worked
HepG2 human liver-derived cells treated with CBD at 5–50 μM for 3–72 hours. DNA double-strand breaks assessed alongside CB1/CB2 cannabinoid receptor expression analysis and cell proliferation measurements.
What this study cannot tell us
Single cell line (HepG2) may not represent all liver cell types. In vitro conditions differ from in vivo metabolism. Only assessed double-strand breaks — other forms of DNA damage not tested. Does not address long-term cumulative exposure. Discrepancy with previous studies needs further investigation.
How to read the evidence
In vitro study using a single cell line, providing mechanistic safety data but requiring replication in additional models.
When this study was published
Published 2025.
The bigger picture
Safety concerns about CBD have increased as millions of people take it daily. This study is part of an important scientific conversation about CBD's true safety profile, and finding no DNA damage in liver cells — where CBD is metabolized — is reassuring for both consumers and regulators.
Questions still open
- Why did previous studies find CBD-induced DNA damage while this one didn't? Could metabolic differences between cell lines explain the discrepancy? Should regulatory agencies reconsider CBD safety warnings based on this evidence?
Common questions
Is CBD safe for the liver?
Why were there concerns about CBD and DNA damage?
Read the original research
Cannabidiol does not cause DNA double-strand breaks in a human liver-derived cell model.
Journal of cannabis research, 8(1), 12
Citation
Weiss, Romano; Liedtke, Victoria; Rödiger, Stefan. (2025). Cannabidiol does not cause DNA double-strand breaks in a human liver-derived cell model.. Journal of cannabis research, 8(1), 12. https://doi.org/10.1186/s42238-025-00365-w
Explore the wider topic
- CBD Oil Quality Guide: How to Avoid Snake Oil
- Anxiety After Quitting Weed: When to Consider Medication
- Cannabis for Chemotherapy Nausea: What the Evidence Actually Shows
- Cannabis for Chronic Pain: What the Research Actually Supports
- Cannabis and Epilepsy: The Epidiolex Story and What It Means
- Does CBD Actually Work for Anxiety? What the Evidence Shows
- Does CBD Help with Weed Withdrawal? What Studies Show
- CBD vs THC: The Differences That Actually Matter
- The Proven Medical Benefits of Cannabis: What Research Supports
- Quitting Weed Before Surgery
- Weed and Medications: What Changes When You Quit
- Quitting Weed During Pregnancy: What You Need to Know
- Quitting Weed While Pregnant: What You Need to Know
- Cannabis and Older Adults: Risks Seniors Should Know
- Cannabis and Breastfeeding: THC in Breast Milk